About
Unleash Immuno Oncolytics develops armed oncolytic viruses that selectively infect both tumor cells and tumor-associated stromal cells to disrupt tumor architecture and elicit systemic immune responses against cancer.
Explore Unleash Immuno Oncolytics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.